Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Asian Institute Of Oncology Private Limited, is an unlisted private company incorporated on 01 January, 2003. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 15.87 cr.
Asian Institute Of Oncology's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's book networth has decreased by 4.3%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2022 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 2
Total Amount : 40.2 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Ramakant Krishnaji Deshpande
Shareholder
|
00374907 | 12 years |
Director | Jagdeesh Narhar Kulkarni
Shareholder
|
01297932 | 22 years |
Director | Sanjay Harishankardhar Sharma
Shareholder
|
07063286 | 10 years |
Additional Director | Varun Deshpande Ramakant | 07868594 | 3 years |
Director | Raghvendra Jagdeesh Kulkarni | 09619429 | 3 years |
Kmp | Divyaprakash Rajendra Dubey | <HIDDEN> | 6 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
TANNA BUILDERS PRIVATE LIMITED |
Active
|
6.9 Cr | 1 | Maharashtra |
ASIAN ONCOLOGY PRIVATE LIMITED |
Active
|
2.0 L | 2 | Maharashtra |
KARNATAKA LEASING AND COMMERCIAL CORPORATION LIMITED |
Active
|
1.2 Cr | 2 | Karnataka |
TRIUMPH ESTATES PRIVATE LIMITED |
Active
|
4.3 Cr | 2 | Maharashtra |
GTOS TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Tamil Nadu |
ASIAN CANCER FOUNDATION |
Active
|
39.1 L | 3 | Maharashtra |
TRIUMPH CANCER INSTITUTE PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
TRIUMPH HOSPITALS PRIVATE LIMITED |
Active
|
7.0 L | 1 | Maharashtra |
ALTERNATIVE PROTEIN SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
GREEN PROTEIN FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
HOPSCOTCH VENTURES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
ASIAN ONCOLOGY PRIVATE LIMITED | Maharashtra | 2016 | ₹ 2.0 L |
TRIUMPH CANCER INSTITUTE PRIVATE LIMITED | Maharashtra | 2018 | ₹ 5.0 L |
The incorporation date of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is 01 January, 2003
The authorized share capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is INR ₹ 25.0 Cr.
The paid-up capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is INR ₹ 15.9 Cr.
The registered address of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is 93/95, Cumbala Hill Hospital August Kranti Marg, Kemps Corner Mumbai Mumbai City Maharashtra - 400036
The CIN number of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is U85110MH2003PTC138491.